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Influenza Virus
Orthomyxoviridea: segmented single-stranded RNA 
genome
divided into influenza A, B and C viruses
annually 3-5 million cases of severe illness worldwide 
and 250,000-500,000 deaths (WHO)
best protection by vaccination annually with trivalent 
seasonal influenza vaccine
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Bioprocess Engineering Group
100 µm
5 h 10 h 22 h 
• 4 days of cell growth to approx. 2.0 x 106 cells/mL
• medium exchange and virus infection with MOI 0.025




Genzel et al., 2004
Cell culture-based vaccine production
MDCK (Madin-Darby canine kidney) cells
Cytodex 1 (dextran) 
microcarriers
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Influenza A/PuertoRico/8/34
Influenza virus strain PR8 variants:
A/PR/8/34 RKI (Robert Koch Institute)




Schulze-Horsel et al., 2009
• amount of differentially 
expressed host proteins
Vester et al., 2010
PR8 variants differ in:
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Limitations by Innate Immune Response?
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Vester et al., 2009
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Signalling Pathways






PWestern blots qRT-PCR for IFN-β and cMx1
infection at a 
low MOI
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Interferon Induction
Björn Heynisch Heynisch et al., 2009 submitted
IFN-mediated signalling / 
activation of the 
antiviral state
T-flask experiments 
with an MOI 5; n=4
IκBα



























































































MOI 5; n=4 MOI 0.025; n=3
T-flask



































































































































































Seitz & Frensing et al., 2010
Interferon Induction
loss of function: 
- Does the inhibition of host defence
increase the virus titre?
gain of function:
- Does the activation of the antiviral 
state reduce the virus yield?
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but: NS1 promotes viral mRNAs translation.
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Loss of function: viral antagonist rP
NS1
rP rP
Inhibition of IFN signalling does not 
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1st infection: MOI 5
ultrafiltration 100 kDa cut-off
2nd infection: 






























































Gain of function: cytokine stimulation
Virus replication is slowed down, 
but almost the same titre is reached
- active virus titre (TCID50)
- MOIs (0.025 / 0.0025 / 0.00025)
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Minireplicon Assay
vRNA (-)
minigenome with reporter gene
Pol-I promoter
FF-Luc








































































































































No inhibitory effects of canine Mx proteins 
Seitz, C. & Frensing, T., Höper, D., Kochs, G., Reichl, U. (2010).
High yields of Influenza A virus in MDCK cells are promoted by an 
insufficient IFN-induced antiviral state. Journal of General Virology, accepted
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• considerable IFN signalling in influenza virus infected MDCK cells
• no impact on final virus titres by inhibition or stimulation of IFN
• lack of inhibitory potential of canine Mx proteins against influenza virus
IFN signalling has only a minor effect on influenza virus replication in MDCK 
cells, which makes these cells an ideal system for high yield vaccine production.
Summary
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